QUANTRO’s proprietary time-resolved functional transcriptomic discovery platform accelerates target screening for complex indications in oncology and inflammationQUANTRO CEO Dr. Michael…
AUSTIN, Texas, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Erisyon, a leading provider of single-molecule proteomics technology, today announced that it…
JERUSALEM, Jan. 7, 2025 /PRNewswire/ -- Senseera, a liquid biopsy company pioneering chromatin epigenomics, announced the successful close of a…
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in…
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in…
Independent director, Jim Alecxih, Chief Executive Officer of DH Medical joins Lumicell's Board of Directors NEWTON, Mass., Jan. 6, 2025…
Bringing decades of clinical leadership to advance symplr's healthcare operations solutions and support patient-centered care HOUSTON, Jan. 6, 2025 /PRNewswire/…
Proceeds from the financing will be used to broaden and improve the company's offerings and for operational expansion across facilities,…
NORTHAMPTON, MA / ACCESSWIRE / January 6, 2025 / Clinical trials are essential for the development of health care products,…
– Approximately $10 million additional investment in private placement equity financing – – $1.5 million from CIRM grant first announced…